For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Clinical trials used by children to study and develop drugs or new drugs are called pediatric clinical trials. Most clinical trials are conducted in adults and very rare clinical trials, including children. To increase the level of participation of children in clinical trials, the United States has developed a regulatory and health strategy that focuses on the overall market for drugs when incorporated into pediatric clinical trials. According to the World Bank Group, approximately 26% of the world's population includes pediatrics (children between the ages of 0-14), rather than 10 times more clinical trials for adults than pediatrics. Because of the lack of pediatric clinical trials, ethical issues, and the infrastructure of pediatric diseases are relatively lower than those found in adults, pharmaceutical companies are paying more attention to drug development in adults.
The Pediatric Clinical Trials market revenue was 19062.24 Million USD in 2022, and will reach 26382.67 Million USD in 2028, with a CAGR of 5.57% during 2022-2028.
This report elaborates the market size, market characteristics, and market growth of the Pediatric Clinical Trials industry, and breaks down according to the type, application, and consumption area of Pediatric Clinical Trials. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leading companies.
In Chapter 2.3 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Pediatric Clinical Trials in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
Chapter 2.5 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 6-10 consider the impact of COVID-19 on the regional economy.
Key players in the global Pediatric Clinical Trials market covered in Chapter 11:
CenterWatch
Quintiles
Duke Clinical Research Institute
Paidion Research, Inc.
Pharmaceutical Product Development LLC
Pfizer Inc
Parexel
Covance Inc.
In Chapter 3, on the basis of types, the Pediatric Clinical Trials market from 2018 to 2028 is primarily split into:
Pre-Clinical
Phase I
Phase II
Phase III
In Chapter 4, on the basis of applications, the Pediatric Clinical Trials market from 2018 to 2028 covers:
Treatment Studies
Observational Studies
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2028) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10:
North America (Covered in Chapter 6)
United States
Canada
Mexico
Europe (Covered in Chapter 7)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 8)
China
Japan
South Korea
Australia
India
Middle East and Africa (Covered in Chapter 9)
Saudi Arabia
UAE
Egypt
South Africa
South America (Covered in Chapter 10)
Brazil
Argentina
Columbia
Years considered for this report:
Historical Years: 2018-2022
Base Year: 2022
Estimated Year: 2023
Forecast Period: 2023-2028